uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis
Show others and affiliations
2014 (English)In: Genome Biology, ISSN 1465-6906, E-ISSN 1474-760X, Vol. 15, no 8, 435- p.Article in journal (Refereed) Published
Abstract [en]

Background: Ductal carcinoma in situ (DCIS) of the breast is a precursor of invasive breast carcinoma. DNA methylation alterations are thought to be an early event in progression of cancer, and may prove valuable as a tool in clinical decision making and for understanding neoplastic development. Results: We generate genome-wide DNA methylation profiles of 285 breast tissue samples representing progression of cancer, and validate methylation changes between normal and DCIS in an independent dataset of 15 normal and 40 DCIS samples. We also validate a prognostic signature on 583 breast cancer samples from The Cancer Genome Atlas. Our analysis reveals that DNA methylation profiles of DCIS are radically altered compared to normal breast tissue, involving more than 5,000 genes. Changes between DCIS and invasive breast carcinoma involve around 1,000 genes. In tumors, DNA methylation is associated with gene expression of almost 3,000 genes, including both negative and positive correlations. A prognostic signature based on methylation level of 18 CpGs is associated with survival of breast cancer patients with invasive tumors, as well as with survival of patients with DCIS and mixed lesions of DCIS and invasive breast carcinoma. Conclusions: This work demonstrates that changes in the epigenome occur early in the neoplastic progression, provides evidence for the possible utilization of DNA methylation-based markers of progression in the clinic, and highlights the importance of epigenetic changes in carcinogenesis.

Place, publisher, year, edition, pages
2014. Vol. 15, no 8, 435- p.
National Category
Medical Genetics
Identifiers
URN: urn:nbn:se:uu:diva-242038DOI: 10.1186/s13059-014-0435-xISI: 000346604100016PubMedID: 25146004OAI: oai:DiVA.org:uu-242038DiVA: diva2:782161
Available from: 2015-01-20 Created: 2015-01-20 Last updated: 2017-12-05Bibliographically approved

Open Access in DiVA

fulltext(2731 kB)206 downloads
File information
File name FULLTEXT01.pdfFile size 2731 kBChecksum SHA-512
cc3d695840380a92801310598b04bed547923edb35c83aac316d0b8c4ffe12f4464d3e2a9b9acc26bb6cd1c76e580f28bf30f8dd056be2b95a561799860422fd
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records BETA

Wärnberg, Fredrik

Search in DiVA

By author/editor
Wärnberg, Fredrik
By organisation
Endocrine Surgery
In the same journal
Genome Biology
Medical Genetics

Search outside of DiVA

GoogleGoogle Scholar
Total: 206 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 672 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf